Clinical Trials: Lowereing A1C, Weight Change & CV Data

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Blood pressure lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA)

Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs - ScienceDirect

PDF) Diabetes treatment intensification and associated changes in HbA1c and body mass index: A cohort study

Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials - Kidney International Supplements

Applying Recent A1C Recommendations in Clinical Practice

Cureus, Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond

Clinical dialogue: Lowering ASCVD risk in a patient with T2DM and obesity - PACE-CME

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

A randomized clinical trial comparing low-fat with precision nutrition–based diets for weight loss: impact on glycemic variability and HbA1c - The American Journal of Clinical Nutrition

EX-99.1